27.00
price down icon7.22%   -2.10
after-market アフターアワーズ: 26.79 -0.21 -0.78%
loading

Janux Therapeutics Inc (JANX) 最新ニュース

pulisher
Mar 28, 2025

Janux Therapeutics stock hits 52-week low at $28.92 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Janux Therapeutics stock hits 52-week low at $28.92 - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - Yahoo Finance

Mar 28, 2025
pulisher
Mar 26, 2025

Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey

Mar 26, 2025
pulisher
Mar 25, 2025

Janux Therapeutics, Inc. (JANX): Among Stocks Receiving the Most Insider Love in March - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

12 Best Up and Coming Stocks to Buy According to Wall Street Analysts - Insider Monkey

Mar 24, 2025
pulisher
Mar 24, 2025

First Week of JANX November 21st Options Trading - Nasdaq

Mar 24, 2025
pulisher
Mar 21, 2025

RA Capital Management, L.P. Increases Stake in Janux Therapeutics Inc - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey

Mar 21, 2025
pulisher
Mar 20, 2025

Is Janux Therapeutics (JANX) a Worst High-Risk High-Reward Growth Stock to Buy? - Insider Monkey

Mar 20, 2025
pulisher
Mar 19, 2025

10 Worst High-Risk High-Reward Growth Stocks To Buy - Insider Monkey

Mar 19, 2025
pulisher
Mar 17, 2025

Commit To Buy Janux Therapeutics At $25, Earn 30% Annualized Using Options - Nasdaq

Mar 17, 2025
pulisher
Mar 14, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

Mar 14, 2025
pulisher
Mar 12, 2025

EGFR Non-Small Cell Lung Cancer Clinical and Non-Clinical - openPR

Mar 12, 2025
pulisher
Mar 12, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Gap Up Following Insider Buying Activity - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Insiders Are Loading Up on These 4 Biotech Stocks Now - 24/7 Wall St.

Mar 11, 2025
pulisher
Mar 11, 2025

(JANX) Proactive Strategies - news.stocktradersdaily.com

Mar 11, 2025
pulisher
Mar 10, 2025

JANX stock touches 52-week low at $29.62 amid market shifts By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

JANX stock touches 52-week low at $29.62 amid market shifts - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Sunday Insider Moves: Top Buys and Sells from Friday’s Disclosures By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Sunday Insider Moves: Top Buys and Sells from Friday’s Disclosures - Investing.com India

Mar 10, 2025
pulisher
Mar 09, 2025

Ra Capital Management, L.P. Purchases 341,742 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Ra Capital Management, L.P. Purchases 110,206 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Major Investment Alert: Janux Therapeutics Stock Sees Massive Buy-In! - TipRanks

Mar 08, 2025
pulisher
Mar 08, 2025

Proficio Capital Partners LLC Invests $1.35 Million in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Ra capital management buys $25.3 million in Janux therapeutics stock By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Ra capital management buys $25.3 million in Janux therapeutics stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

HC Wainwright Has Pessimistic Outlook of JANX Q1 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Janux Therapeutics (JANX) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Janux Therapeutics chief business officer sells shares for $107,174 By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Given Consensus Rating of “Buy” by Brokerages - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Janux Therapeutics chief business officer sells shares for $107,174 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey

Mar 05, 2025
pulisher
Mar 05, 2025

JANUX THERAPEUTICS Earnings Preview: Recent $JANX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

10 Stocks With At Least $30 Million In Insider Spending Recently - Insider Monkey

Mar 05, 2025
pulisher
Mar 04, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Rhumbline Advisers - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Stock Holdings Lifted by New York State Common Retirement Fund - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Janux Therapeutics (NASDAQ:JANX) Given “Buy” Rating at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Janux Therapeutics (NASDAQ:JANX) Sets New 52-Week Low on Analyst Downgrade - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Promising Developments and Strong Financial Position Support Buy Rating for Janux Therapeutics - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Janux Therapeutics’ (JANX) Outperform Rating Reiterated at Wedbush - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Positive Outlook for Janux Therapeutics Inc. Driven by Unique Therapeutic Potential and Strategic Advantages - TipRanks

Mar 02, 2025
pulisher
Mar 01, 2025

Janux Therapeutics price target lowered to $41 from $62 at Scotiabank - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Janux Therapeutics Reports Strong Financial Position and Clinical Progress - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Janux Therapeutics (NASDAQ:JANX) Announces Quarterly Earnings Results, Beats Estimates By $0.13 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Analyst Recommends ‘Buy’ for Janux Therapeutics Inc. Amid Share Price Decline and Promising Clinical Outlook - TipRanks

Feb 28, 2025
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):